Test it yourself. If it fails, you get a full refund.
Independent test fails? Full refund.
Independent test fails? Full refund.
10 vials per kit, from 1 kit per product and strength. We reply to every quote request within 24 hours. How quotes work →
10 vials per kit · from 1 kit · reply within 24 hours Quotes →
10 vials per kit · from 1 kit Quotes →
GLP-1 analogue fused through a peptide linker to a modified human IgG4 Fc domain
Research topic: Body & metabolism · group: GLP-1 class and amylin analogues
Dulaglutide is a fusion protein: a modified GLP-1(7-37) sequence joined through a glycine-serine linker to the Fc part of human IgG4, built from two identical chains of 275 residues that form a homodimer. That makes it a protein many times the size of the acylated GLP-1 peptides on this site, with identity checked by peptide mapping. The same molecule is the active ingredient of approved medicines; the vials we supply are research material, not a medicine. It is listed in the GLP-1 and amylin group of our body-composition and metabolic page. The trials in our product data appear under their study names, because the records give no first authors; in most of them dulaglutide was the comparator, against semaglutide or tirzepatide in type 2 diabetes, and one enrolled young people.
Same molecule, not a medicine
Dulaglutide is the active ingredient of approved medicines. What we supply is the same molecule, but not a medicine: lyophilized research material in vials, not a finished drug product.
The COA of every lot of Dulaglutide reports:
Ask for the COA of the batch you are quoted; the batch number on it is the batch we ship.
Independent test fails? Full refund. How the refund works
| Field | Value | Source |
|---|---|---|
| Chemical name | Dulaglutide | Our product table |
| Other names | LY2189265 · GLP-1-Fc fusion protein | Our product table |
| Molecular formula | C2646H4044N704O836S18 | Our product table |
| Molecular weight | 59670.6 g/molCalculated from the formula shown; our product table gives no value. | Calculated from the formula (standard atomic weights) |
| CAS number | 923950-08-7PubChem holds no compound record for the whole fusion protein; the identity rests on the CAS and the GSRS substance record. | Our product table |
| Strengths (per vial) | 5 mg, 10 mg | Our product table |
| Kit and minimum order | 10 vials per kit · from 1 kit per strength | Our product table |
| Form | Lyophilized powder | Our product table |
| Catalogue codes | 5 mg: DUL5 · 10 mg: DUL10 | Our product table |
| Purity specification | ≥ 99.0% (HPLC)Specification; the measured value is on the COA of the lot. | Our product table |
| Appearance | White to off-white lyophilized powder | Our product table |
| Storage | Store at 2–8 °C, protected from light and moisture | Our product table |
| Batch COA | HPLC purity · MS identity · endotoxin · fill — every lot | Our batch COA |
Product-table values checked 2026-10-09. The measured values of a lot are on its COA.
| First author / trial | Year | Journal | What was studied | Record |
|---|---|---|---|---|
| SUSTAIN 7 trial | 2018 | Lancet Diabetes Endocrinol | Open-label phase 3b comparison with semaglutide in type 2 diabetes | PubMed 29397376 |
| SURPASS J-mono trial | 2022 | Lancet Diabetes Endocrinol | Tirzepatide compared with dulaglutide in Japanese people with type 2 diabetes | PubMed 35914543 |
| AWARD-PEDS trial | 2022 | N Engl J Med | Randomised trial in young people with type 2 diabetes | PubMed 35658022 |
| SURPASS-CVOT trial | 2025 | N Engl J Med | Cardiovascular outcomes compared with dulaglutide in type 2 diabetes | PubMed 41406444 |
Studies recorded in our product data (checked 2026-10-09). They show what has been researched with this molecule — the materials and models of each study — and are not a statement about the vials we supply.
What to put in your quote request
With these facts the first reply can carry the unit price per kit, shipping and lead time.
Its active portion is a GLP-1 analogue, and it is researched alongside the other GLP-1 receptor agonists. The Fc portion makes the whole molecule a protein, so its identity is confirmed by peptide mapping and its minimum order is stated per product.
Each Fc chain carries a consensus site for N-glycosylation. Our product data do not record how far it is occupied, so the glycan profile is a property of each lot, to be confirmed on its COA.
It is the same molecule. Approved dulaglutide products are finished medicines in devices with their own labelling; we supply lyophilized research material, which is not a medicine.
One kit is 10 vials of the same product at the same strength. Each vial holds the stated amount, for example 10 mg of lyophilized peptide; the few solutions are stated per vial in mg or ml. 1 kit per product and strength. One order can combine several products and strengths, each from 1 kit.
HPLC purity, MS identity, endotoxin and fill, on the COA of every lot of a stocked peptide. The COA carries the lot number, so you can match it to the vials you receive. Yes. Ask for the COA of the batch you are quoted; the batch number on that COA is the batch we ship.
In writing, per request. Prices are tiered by the number of kits of each peptide and strength; the quotation gives the unit price per kit, the shipping cost and the lead time. We reply within 24 hours.
Because listings describe different forms: a free peptide or a salt (acetate, TFA), a copper complex or its free peptide, one peptide or a two-peptide material — and some registries keep older numbers. Each product page says which form its values refer to; the COA of the lot is the reference. For Dulaglutide: PubChem holds no compound record for the whole fusion protein; the identity rests on the CAS and the GSRS substance record.
Related peptides
31-mer
Acylated GLP-1 analogue of 31 residues with a C16 palmitoyl side chain
Nasal spray available
Lipidated GLP-1 receptor agonist peptide of 31 residues
Nasal spray available
Dual GIP and GLP-1 receptor agonist peptide of 39 residues
Nasal spray available